title: Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: a phase I trial of safety and efficacy in the nasal airway.
authors.forename: E J
authors.initials: EJ
authors.lastname: Sorscher
authors.forename: J J
authors.initials: JJ
authors.lastname: Logan
authors.forename: R A
authors.initials: RA
authors.lastname: Frizzell
authors.forename: R K
authors.initials: RK
authors.lastname: Lyrene
authors.forename: Z
authors.initials: Z
authors.lastname: Bebok
authors.forename: J Y
authors.initials: JY
authors.lastname: Dong
authors.forename: M D
authors.initials: MD
authors.lastname: Duvall
authors.forename: P L
authors.initials: PL
authors.lastname: Felgner
authors.forename: S
authors.initials: S
authors.lastname: Matalon
authors.forename: L
authors.initials: L
authors.lastname: Walker
mesh_terms: D000281:Administration, Intranasal; D002985:Clinical Protocols; D003550:Cystic Fibrosis / Q000628:therapy*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D007258:Informed Consent; D008081:Liposomes; D008565:Membrane Proteins / Q000235:genetics*
chemical_list: C505032:CFTR protein, human; D008081:Liposomes; D008565:Membrane Proteins; D019005:Cystic Fibrosis Transmembrane Conductance Regulator